Clinical Trial Update: Action of Ketamine in Treatment-Resistant Depression [Phase 2, Phase 3]

View source ↗

Summary

The document summarizes the completion status of Phase 2 and Phase 3 trials evaluating ketamine for treatment-resistant depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Ottawa | Conditions: Treatment-resistant Depression | Phase 2, Phase 3 | Status: COMPLETED